According to CBS News, US National Academy of Sciences had to take down a video and tweet it posted earlier this week on gene editing.
The NAM, NAS, and Royal Society have formed a commission to develop a framework on the proper use of genome editing, and convened its first meeting in Washington, DC, this week.
US National Academy of Science has voted to allow members who violate its code of conduct to be expelled, according to ScienceInsider.
An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.
The commission will develop a framework for scientists, clinicians, and regulatory authorities on the appropriate use of human germline genome editing.
In an initial vote, the US National Academy of Sciences approved an amendment to allow the expulsion of members who violate its code of conduct, according to the Verge.
A commentary appearing in Nature calls for the establishment of a research policy board in the US.
In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
A new report urges investigators to routinely consider returning research results to study participants, according to Stat News.
Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.
University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.
NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.
In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.